Alfred Furth

1.6k total citations
21 papers, 1.1k citations indexed

About

Alfred Furth is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Alfred Furth has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Alfred Furth's work include Colorectal Cancer Treatments and Studies (6 papers), DNA Repair Mechanisms (3 papers) and Brain Metastases and Treatment (3 papers). Alfred Furth is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), DNA Repair Mechanisms (3 papers) and Brain Metastases and Treatment (3 papers). Alfred Furth collaborates with scholars based in United States. Alfred Furth's co-authors include Jan C. Buckner, Karla V. Ballman, Sumithra J. Mandrekar, Kenneth Aldape, C. David James, Stephen Seiler, Jayawant N. Mandrekar, Brent A. Williams, Peter C. Burger and Robert B. Jenkins and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Alfred Furth

21 papers receiving 1.1k citations

Peers

Alfred Furth

GENET

ONCOL

MB

PRM

CR

Kevin Li United States

Preston D. Steen United States

Philip Kahl Germany

Elsie Oppermann Germany

Christine M. Kearns United States

Min Yuen Teo United States

Kazumasa Komura Japan

Anna M. Dahlin Sweden

R. Kath Germany

Christian Haslinger Switzerland

Kevin Li United States

Alfred Furth

316 ×0.8

GENET

394 ×1.1

ONCOL

627 ×2.1

MB

72 ×0.3

PRM

122 ×0.6

CR

Citations per year, relative to Alfred Furth Alfred Furth (= 1×) peers Kevin Li

Countries citing papers authored by Alfred Furth

Since Specialization

Citations

This map shows the geographic impact of Alfred Furth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred Furth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred Furth more than expected).

Fields of papers citing papers by Alfred Furth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfred Furth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred Furth. The network helps show where Alfred Furth may publish in the future.

Co-authorship network of co-authors of Alfred Furth

This figure shows the co-authorship network connecting the top 25 collaborators of Alfred Furth. A scholar is included among the top collaborators of Alfred Furth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfred Furth. Alfred Furth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Furth, Alfred, et al.. (2014). Improving Student Success in Calculus I using a Co-requisite Calculus I Lab. PRIMUS. 25(4). 381–387. 4 indexed citations

2.

Furth, Alfred, et al.. (2009). Cumulative Gains Model Quality Metric. Journal of Applied Mathematics and Decision Sciences. 2009. 1–14. 7 indexed citations

3.

Pelloski, Christopher E., Karla V. Ballman, Alfred Furth, et al.. (2007). Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma. Journal of Clinical Oncology. 25(16). 2288–2294. 239 indexed citations

4.

Furth, Alfred, Sumithra J. Mandrekar, Angelina D. Tan, et al.. (2007). A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin. Cancer Chemotherapy and Pharmacology. 61(1). 39–45. 2 indexed citations

5.

Molina, Julian R., J. Fernando Quevedo, Alfred Furth, et al.. (2007). Predictors of survival from urachal cancer. Cancer. 110(11). 2434–2440. 113 indexed citations

6.

Furth, Alfred & Daniel J. Sargent. (2006). Duffy-Santner Confidence Intervals for the Two-Stage Three-Outcome Design. Journal of Biopharmaceutical Statistics. 16(6). 875–880. 1 indexed citations

7.

Williams, Brent A., Jayawant N. Mandrekar, Sumithra J. Mandrekar, Stephen Seiler, & Alfred Furth. (2006). Finding Optimal Cutpoints for Continuous Covariates with Binary and Time-to-Event Outcomes. 145 indexed citations

8.

Molina, Julian R., Joel M. Reid, Charles Erlichman, et al.. (2005). A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin. Anti-Cancer Drugs. 16(9). 997–1002. 25 indexed citations

9.

Laack, Nadia N., Paul D. Brown, Robert J. Ivnik, et al.. (2005). Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study. International Journal of Radiation Oncology*Biology*Physics. 63(4). 1175–1183. 125 indexed citations

10.

Miller, Robert C., Michael G. Haddock, Ivy A. Petersen, Leonard L. Gunderson, & Alfred Furth. (2005). Intraoperative electron-beam radiotherapy and ureteral obstruction. International Journal of Radiation Oncology*Biology*Physics. 64(3). 792–798. 11 indexed citations

11.

Dy, Grace K., Sumithra J. Mandrekar, Prema P. Peethambaram, et al.. (2005). A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 56(6). 623–628. 7 indexed citations

12.

Dy, Grace K., Laura M. Bruzek, Gary A. Croghan, et al.. (2005). A Phase I Trial of the Novel Farnesyl Protein Transferase Inhibitor, BMS-214662, in Combination with Paclitaxel and Carboplatin in Patients with Advanced Cancer. Clinical Cancer Research. 11(5). 1877–1883. 23 indexed citations

13.

Aldape, Kenneth, Karla V. Ballman, Alfred Furth, et al.. (2004). Immunohistochemical Detection of EGFRvIII in High Malignancy Grade Astrocytomas and Evaluation of Prognostic Significance. Journal of Neuropathology & Experimental Neurology. 63(7). 700–707. 202 indexed citations

14.

Dy, Grace K., Lorelei J. Hanson, Alfred Furth, et al.. (2004). Complementary and Alternative Medicine Use by Patients Enrolled Onto Phase I Clinical Trials. Journal of Clinical Oncology. 22(23). 4810–4815. 98 indexed citations

15.

Haluska, Paul, D O Toft, Alfred Furth, et al.. (2004). A phase I trial of gemcitabine (Gem), 17-allylaminogeldanamycin (17-AAG) and cisplatin (CDDP) in solid tumor patients. Journal of Clinical Oncology. 22(14_suppl). 3058–3058. 3 indexed citations

16.

Burgart, Lawrence J., Michelle R. Mahoney, Harold E. Windschitl, et al.. (2004). Prognostic Value of Proliferation, Apoptosis, Defective DNA Mismatch Repair, and p53 Overexpression in Patients With Resected Dukes' B2 or C Colon Cancer. Journal of Clinical Oncology. 22(9). 1572–1582. 108 indexed citations

17.

Rao, Ravi D., Joel M. Reid, Matthew P. Goetz, et al.. (2004). Phase I trial of OSI-774 and CPT-11 in patients with advanced solid tumors. Journal of Clinical Oncology. 22(14_suppl). 3053–3053. 1 indexed citations

18.

Rao, Ravi D., Joel M. Reid, Matthew P. Goetz, et al.. (2004). Phase I trial of OSI-774 and CPT-11 in patients with advanced solid tumors. Journal of Clinical Oncology. 22(14_suppl). 3053–3053. 1 indexed citations

19.

Haluska, Paul, D O Toft, Alfred Furth, et al.. (2004). A phase I trial of gemcitabine (Gem), 17-allylaminogeldanamycin (17-AAG) and cisplatin (CDDP) in solid tumor patients. Journal of Clinical Oncology. 22(14_suppl). 3058–3058. 9 indexed citations

20.

Laack, Nadia N., Paul D. Brown, Alfred Furth, et al.. (2003). Neurocognitive function after radiotherapy (RT) for supratentorial low-grade gliomas (LGG): results of a north central cancer treatment group (NCCTG) prospective study. International Journal of Radiation Oncology*Biology*Physics. 57(2). S134–S134. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact